Health & Science Technologies — Cost of Sales
IDEX Health & Science Technologies — Cost of Sales decreased by 5.2% to $231.3M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from $201.2M to $231.3M. Over 3 years (FY 2022 to FY 2025), Health & Science Technologies — Cost of Sales shows an upward trend with a 6.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase relative to sales suggests margin compression, while a decrease relative to sales indicates improved manufacturing efficiency.
Detailed definition
Includes the direct costs attributable to the production of goods and services sold within the Health and Science Techno...
Peer comparison
Standard cost of goods sold metric for manufacturing segments across industrial and medical technology companies.
iex_segment_health_science_technologies_cost_of_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $184.73M | $184.73M | $184.73M | $184.73M | $195.78M | $195.78M | $195.78M | $195.78M | $184.3M | $177.6M | $184.1M | $223.5M | $201.2M | $217M | $223.3M | $244M | $231.3M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.0% | +0.0% | +0.0% | +0.0% | -5.9% | -3.6% | +3.7% | +21.4% | -10.0% | +7.9% | +2.9% | +9.3% | -5.2% |
| YoY Change | — | — | — | — | +6.0% | +6.0% | +6.0% | +6.0% | -5.9% | -9.3% | -6.0% | +14.2% | +9.2% | +22.2% | +21.3% | +9.2% | +15.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IDEX's health & science technologies — cost of sales?
- IDEX (IEX) reported health & science technologies — cost of sales of $231.3M in Q1 2026.
- How has IDEX's health & science technologies — cost of sales changed year-over-year?
- IDEX's health & science technologies — cost of sales increased by 15.0% year-over-year, from $201.2M to $231.3M.
- What is the long-term trend for IDEX's health & science technologies — cost of sales?
- Over 3 years (2022 to 2025), IDEX's health & science technologies — cost of sales has grown at a 6.2% compound annual growth rate (CAGR), from $738.9M to $885.5M.
- What does health & science technologies — cost of sales mean?
- The direct costs incurred to produce the goods sold by the Health and Science Technologies segment.